Developmental Activities:

Non-Human Clinical Studies

  • cGMP fill and finish operations for pre-filled syringes and auto-injector systems
  • Chemistry and Manufacturing Control (CMC) sections of a Drug Application
  • Identification and qualification of suppliers of device components and assemblies
  • drug solution excipients and active pharmaceutical ingredients (API)
  • Formulation development
  • Container closure system manufacturers in the selection of drug contact materials
  • ICH shelf-life studies
  • Assay method and specifications for API, excipients and final drug product
  • Identification of drug impurities
  • Toxicology studies per FDA Guidelines

MSA News

Progress During the Pandemic

August 31, 2020 – Our surviving the Covid-19 experience has been an example of what having a great team can…

Read More

MSA and COVID-19

Frederick, MD July 17, 2020 – MSA has decided to delay the full-time return to our Frederick offices indefinitely.  Unfortunately,…

Read More

Mesa Science Associates and Bryn Pharma Publish Final of Three Pre-Clinical Studies of a New Approach to Treating Anaphylaxis

The third in a series of studies measured cerebrospinal fluid epinephrine pharmacokinetics, nasal mucosa effects, plasma epinephrine pharmacokinetics, and cardiovascular…

Read More